Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was conducted to investigate the effect of video playback of children's laughter on anxiety, nausea, vomiting and fatigue levels of patients during chemotherapy
Nausea and vomiting, anxiety and fatigue due to chemotherapy can be prevented or reduced with effective nursing interventions and care. Laughter therapy is an intervention that has been used in the symptom management of individuals with cancer in recent years. Studies focusing on humor and laughter have generally been conducted among cancer patients. Humor and laughter have been shown to have both physiological, psychological and sociological benefits for patients in general. When the studies on laughter yoga are examined, it is seen that the results of laughter therapy applied to individuals are examined. It has also been reported in the literature that laughter has a contagious effect, often occurring in groups of people. There is no study in the literature on the effect of children's laughter on adults. This study will reveal the effectiveness of infant and child laughter in patients receiving chemotherapy. It is thought that this study will constitute an important data source for experimental studies to be conducted.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Child laughter video group | Experimental | Patients in this group were made to watch the laughter video prepared by the researchers at the end of the 1st and 2nd hour after the start of chemotherapy. |
|
| Control Group | No Intervention | Participants in the control group were not subjected to any intervention other than routine practice during chemotherapy. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Child laughter video | Behavioral | 1 hour after the chemotherapy treatment was started, the video monitor was placed at a height where the patient could see comfortably while lying down and the video, which was checked and prepared beforehand, was turned on full screen. The appropriate volume was adjusted and the patient was allowed to watch the video for 10 minutes without any other intervention. The video was then stopped and the etagere was removed from in front of the patient. Chemotherapy was continued. At the 2nd hour of chemotherapy, the disinfected etagere and computer were placed in a position where the patient could see them comfortably and the 2nd video was started and the patient was allowed to watch the video for 10 minutes. |
| Measure | Description | Time Frame |
|---|---|---|
| Patient information form | The form was designed by the researchers in two parts to assess personal characteristics and characteristics related to the disease and treatment. | First measurement-10. minutes before the start of the patient's chemotherapy |
| Spielberger State Anxiety Scale | The scale measures the level of status anxiety of the patient with 20 questions.this form was applied in the pre-test and post-test phase | First measurement- 5 minutes before the start of the patient's chemotherapy |
| FACIT Fatigue Scale | Developed by Singh in 2014, the scale was developed to evaluate the relationship between anemia and fatigue in cancer patients and to meet the increasing demand. This form was applied in the pre-test and post-test phase. | First measurement- 1 minutes before the start of the patient's chemotherapy |
| Physiological Parameter Follow-up Form (Heart rate-min) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. | As soon as chemotherapy is started (Within first five minute) |
| Physiological Parameter Follow-up Form (Respiration rate- min) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. | As soon as chemotherapy is started (Within first five minute) |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. |
| Measure | Description | Time Frame |
|---|---|---|
| Physiological Parameter Follow-up Form (Heart rate-min) | The measurement was made immediately after the first hour was full. | Second measurement: 1. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Respiration rate- min) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sibel Kucukoglu, Prof | Selcuk University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sibel Küçükoğlu | Selçuklu | Akademi Mahallesi | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| D007845 | Laughter |
| D005221 | Fatigue |
| D009325 | Nausea |
| D014839 | Vomiting |
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
| D009633 | Nonverbal Communication |
| D003142 | Communication |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| As soon as chemotherapy is started (Within first five minute) |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | This form was created by researchers. When chemotherapy started and measured at the beginning of each hour. | As soon as chemotherapy is started (Within first five minute) |
| Nausea Follow-up Form | With this form, the presence or absence of the patient's nause was questioned.Nausea was first measured at the start of chemotherapy | As soon as chemotherapy is started (Within first five minute) |
| Vomiting Follow-up Form | With this form, the presence or absence of the patient's vomiting was questioned. Vomiting was first measured at the start of chemotherapy | As soon as chemotherapy is started (Within first five minute) |
The measurement was made immediately after the first hour was full.
| Second measurement: 1. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | The measurement was made immediately after the first hour was full. | Second measurement: 1. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | The measurement was made immediately after the first hour was full. | Second measurement: 1. hour after starting chemotherapy |
| Nausea Follow-up Form | The measurement was made immediately after the first hour was full. | Second measurement: 1. hour after starting chemotherapy |
| Vomiting Follow-up Form | The measurement was made immediately after the first hour was full. | Second measurement: 1. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Heart rate-min) | The measurement was made immediately after the second hour was full. | Third measurement: 2. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Respiration rate- min) | The measurement was made immediately after the second hour was full. | Third measurement: 2. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | The measurement was made immediately after the second hour was full. | Third measurement: 2. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | The measurement was made immediately after the second hour was full. | Third measurement: 2. hour after starting chemotherapy |
| Nausea Follow-up Form | The measurement was made immediately after the second hour was full. | Third measurement: 2. hour after starting chemotherapy |
| Vomiting Follow-up Form | The measurement was made immediately after the second hour was full. | Third measurement: 2. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Heart rate-min) | The measurement was made immediately after the third hour was full. | Fourth measurement: 3. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Respiration rate- min) | The measurement was made immediately after the third hour was full. | Fourth measurement: 3. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | The measurement was made immediately after the third hour was full. | Fourth measurement: 3. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | The measurement was made immediately after the third hour was full. | Fourth measurement: 3. hour after starting chemotherapy |
| Nausea Follow-up Form | The measurement was made immediately after the third hour was full. | Fourth measurement: 3. hour after starting chemotherapy |
| Vomiting Follow-up Form | The measurement was made immediately after the third hour was full. | Fourth measurement: 3. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Heart rate-min) | The measurement was made immediately after the fourth hour was full. | Fifth measurement: 4. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (Respiration rate- min) | The measurement was made immediately after the fourth hour was full. | Fifth measurement: 4. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (oxygen saturation -SpO2%) | The measurement was made immediately after the fourth hour was full. | Fifth measurement: 4. hour after starting chemotherapy |
| Physiological Parameter Follow-up Form (blood pressure- mmHg) | The measurement was made immediately after the fourth hour was full. | Fifth measurement: 4. hour after starting chemotherapy |
| Nausea Follow-up Form | The measurement was made immediately after the fourth hour was full. | Fifth measurement: 4. hour after starting chemotherapy |
| Vomiting Follow-up Form | The measurement was made immediately after the fourth hour was full. | Fifth measurement: 4. hour after starting chemotherapy |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012817 | Signs and Symptoms, Digestive |